{
    "medicine_id": "ab4bc1fea47aa3b6398a07db47de89d82ae05685",
    "platform_id": "DB08833",
    "metadata": {
        "name": "Erivedge 150 mg 1 Capsule",
        "composition": "150 mg 1 Taurochenodeoxycholic acid",
        "clinical_particulars": {
            "therapeutic_indications": "Taurochenodeoxycholic acid is likely indicated as a choleretic and cholagogue It is also being investigated for its role in inflammation and cancer therapy",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding and bruising can be increased when Lepirudin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding and bruising can be increased when Alteplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding and bruising can be increased when Reteplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding and bruising can be increased when Drotrecogin alfa is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding and bruising can be increased when Streptokinase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dicoumarol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding and bruising can be increased when Argatroban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ardeparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding and bruising can be increased when Phenindione is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding and bruising can be increased when Fondaparinux is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding and bruising can be increased when Pentosan polysulfate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding and bruising can be increased when Phenprocoumon is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding and bruising can be increased when Heparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding and bruising can be increased when Enoxaparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding and bruising can be increased when Acenocoumarol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding and bruising can be increased when 4 hydroxycoumarin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding and bruising can be increased when Coumarin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding and bruising can be increased when Desmoteplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ancrod is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding and bruising can be increased when Fibrinolysin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding and bruising can be increased when Semuloparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding and bruising can be increased when Idraparinux is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding and bruising can be increased when Astaxanthin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding and bruising can be increased when Apixaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding and bruising can be increased when Otamixaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding and bruising can be increased when Amediplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding and bruising can be increased when Danaparoid is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dalteparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tinzaparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ferulic acid is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding and bruising can be increased when R warfarin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ethyl biscoumacetate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nadroparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding and bruising can be increased when Ditazole is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding and bruising can be increased when Edoxaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding and bruising can be increased when Potassium citrate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding and bruising can be increased when Sodium citrate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dextran is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding and bruising can be increased when Bemiparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding and bruising can be increased when Parnaparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding and bruising can be increased when Desirudin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding and bruising can be increased when Antithrombin Alfa is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein C is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding and bruising can be increased when Antithrombin III human is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding and bruising can be increased when Letaxaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding and bruising can be increased when Darexaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding and bruising can be increased when Monteplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding and bruising can be increased when Gabexate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding and bruising can be increased when Fluindione is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding and bruising can be increased when Protein S human is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding and bruising can be increased when Brinase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding and bruising can be increased when Clorindione is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding and bruising can be increased when Diphenadione is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tioclomarol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding and bruising can be increased when Melagatran is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding and bruising can be increased when Saruplase is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding and bruising can be increased when S Warfarin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding and bruising can be increased when Tocopherylquinone is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding and bruising can be increased when Edetate calcium disodium anhydrous is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding and bruising can be increased when Dabigatran is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding and bruising can be increased when Zinc citrate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding and bruising can be increased when Troxerutin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding and bruising can be increased when Edetic acid is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding and bruising can be increased when Reviparin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of adverse effects can be increased when Eptifibatide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of adverse effects can be increased when Ticlopidine is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of adverse effects can be increased when Anagrelide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of adverse effects can be increased when Clopidogrel is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of adverse effects can be increased when Tirofiban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of adverse effects can be increased when Dipyridamole is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of adverse effects can be increased when Iloprost is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of adverse effects can be increased when Cilostazol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of adverse effects can be increased when Ridogrel is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of adverse effects can be increased when Resveratrol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of adverse effects can be increased when Nimesulide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of adverse effects can be increased when Tesmilifene is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of adverse effects can be increased when Defibrotide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of adverse effects can be increased when Beraprost is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of adverse effects can be increased when Ibudilast is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of adverse effects can be increased when Andrographolide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of adverse effects can be increased when Caplacizumab is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of adverse effects can be increased when Prasugrel is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of adverse effects can be increased when Cangrelor is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of adverse effects can be increased when Tranilast is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of adverse effects can be increased when Triflusal is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of adverse effects can be increased when Ticagrelor is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of adverse effects can be increased when Vorapaxar is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of adverse effects can be increased when Trapidil is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of adverse effects can be increased when Naftopidil is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Sarpogrelate is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of adverse effects can be increased when Ifetroban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Ketanserin is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of adverse effects can be increased when Indobufen is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of adverse effects can be increased when Butylphthalide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of adverse effects can be increased when Ramatroban is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of adverse effects can be increased when Picotamide is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of adverse effects can be increased when Cloricromen is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of adverse effects can be increased when Linsidomine is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of adverse effects can be increased when Buflomedil is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of adverse effects can be increased when Relcovaptan is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11081",
                        "description": "Aluminum chloride can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "Colestipol can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00658",
                        "description": "Sevelamer can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00930",
                        "description": "Colesevelam can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01432",
                        "description": "Cholestyramine can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Ormeloxifene"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Norgestrienone"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Megestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Ethynodiol diacetate"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Gestodene"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Dienogest"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Norethynodrel"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Norgestrel"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Gestrinone"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Lynestrenol"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Chlormadinone"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Quingestanol"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Demegestone"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Nomegestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Clofibrate"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Etofibrate"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Ciprofibrate"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Simfibrate"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Ronifibrate"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Aluminium clofibrate"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Clofibride"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Fenofibric acid"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Sucralfate"
                    },
                    {
                        "drugbank-id": "DB00516",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Bentoquatam"
                    },
                    {
                        "drugbank-id": "DB01575",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Kaolin"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Magaldrate"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Potassium alum"
                    },
                    {
                        "drugbank-id": "DB11239",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB11306",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Bentonite"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminium acetoacetate"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminium glycinate"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB13654",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Montmorillonite"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminium phosphate"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Taurochenodeoxycholic acid can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}